Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab Cannabis Investing News
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm Biotech Investing
ROSEN, A RESPECTED LAW FIRM, Encourages BELLUS Health Inc. Investors With Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision Medical Device Investing
Bristol Myers Squibb Presents Positive Data from Two Pivotal Phase 3 Psoriasis Studies Demonstrating Superiority of Deucravacitinib Compared to Placebo and Otezla® Biotech Investing
AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Onureg® as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia in First Remission Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Biotech Investing
AbbVie Receives Health Canada Approval of HUMIRA® for the Treatment of Pediatric Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris Medical Device Investing
